Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinoma.

Name: Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinoma.
Author: Szigetvari, Nicholas M

Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinoma. — المؤلف: Szigetvari, Nicholas M — Oncotarget Dec 2018

المؤلف: Szigetvari, Nicholas M
النشر: Oncotarget Dec 2018
الوصف: 37042-37053 p.